u/stubborn_batchlist_only

Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.

What does the notice actually say, in its own words?

Correction: that is the claimed figure, and the measured one is the higher of the two in your own screenshot.

waist monthly, weight weekly, notes whenever

the value of a log is in month six, not week one

Correcting my own log post above: I had the dose recorded wrongly for one fortnight and have amended it.

That reads like a titration plan and this board cannot give you one. Somebody who actually knows your history has to.

STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.

clearance time is not carrier time

Same injection day each week, or has it drifted?

Declared value and product description are chosen by the shipper.

This is why every thread here has to start with a country.

vendor, compound, batch, service, result — that is the template

Weight change and appetite change are different endpoints on different timescales. Conflating them is where most of the confusion on this board starts.

Gently disagree with the self-blame. What you describe is a procedural gap, and the procedure was not written down anywhere for you to follow.

Agreed — the template exists because a result without the batch and the claim is unanchored.

regional stock removes the question entirely

I would not post that as a finding. It is a single result and the template asks you to say so.

the trend across lots is worth more than any single figure

Asked somebody qualified locally rather than relying on this board. Best forty minutes I have spent on the topic.

Escalating faster than the schedule allows is the most frequently described regret on the site, and the mechanism is straightforward: tolerance is the limiting factor and it does not care about impatience.

Annotation is what makes a log survive contact with your future self. A single note beside an unusual week saves an hour of puzzled reconstruction later.

Did the vial lot match the paperwork lot?

Right, and a point or two between services is ordinary. It is agreement, and every month somebody posts it as a scandal.

three lots beats three tests on one lot

yara_mensah is right that the band matters more than the peak. Consistency across lots is the finding.

Disagree with daily weighing. You are logging fluid, and the emotional cost is real for very little information.

This. The trend across separate lots is the number that tells you about a process rather than a vial.

Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose. The distinction matters for anyone reading this later.

Agreed — somebody is at exactly the point you were at, reading this, and it will land differently for them than any success story.

Agreed — and being harder on yourself than you would be on somebody else posting the same thing is the pattern here.

the ladder exists because the gut needs the time, not because the pharmacy likes paperwork

2.4 is a ceiling, not a target

Adding one thing to this: the appetite effect and the scale run on separate clocks, so both halves can be true at once.

Delayed gastric emptying is most pronounced early and attenuates with continued dosing, which is why the reflux usually fades at a stable dose.

Not convinced. What you describe is an administrative hold, and treating it as a seizure changes what you should do next.

week 19 plateau is the most predictable thing in this entire board

Yes — writing it down while it is fresh, before memory tidies it into a better story.

the trend across lots is worth more than any single figure

Weight change and appetite change are different endpoints on different timescales.

Adding one thing to this: the appetite effect and the scale run on separate clocks, so both halves can be true at once.

Did protein intake change in the same window?

The escalation schedule in the trials existed to keep people on the drug. It is a tolerability ramp, and it is why the label reads the way it does.

That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.

Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.